DEPDC5 downregulation was also observed in tumors of breast cancer patients [53], where it is strongly correlated with the upregulation of KLHL22 E3-ubiquitin ligase, responsible for DEPDC5 polyubiquitylation and degradation (see above). This evidence concerns the gene DEPDC5 and breast carcinoma.